PT Metro Healthcare Indonesia Tbk (IDX:CARE)
Indonesia
· Delayed Price · Currency is IDR 408.00
0.00 (0.00%)
Apr 28, 2026, 4:00 PM WIB
IDX:CARE Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 439,752 | 319,022 | 242,681 | 260,426 | 290,934 | Upgrade
|
| Revenue Growth (YoY) | 37.84% | 31.46% | -6.81% | -10.49% | 34.51% | Upgrade
|
| Cost of Revenue | 226,845 | 216,317 | 154,716 | 166,533 | 146,481 | Upgrade
|
| Gross Profit | 212,906 | 102,705 | 87,965 | 93,893 | 144,454 | Upgrade
|
| Selling, General & Admin | 132,207 | 124,652 | 115,939 | 145,618 | 120,302 | Upgrade
|
| Other Operating Expenses | 10,662 | 6,703 | 7,782 | 8,663 | 8,748 | Upgrade
|
| Operating Expenses | 142,890 | 132,633 | 124,104 | 154,484 | 130,356 | Upgrade
|
| Operating Income | 70,016 | -29,928 | -36,139 | -60,591 | 14,098 | Upgrade
|
| Interest Expense | -76,522 | -74,565 | -75,775 | -89,333 | -25,432 | Upgrade
|
| Interest & Investment Income | 15,555 | 6,243 | 6,623 | 31,785 | 15,782 | Upgrade
|
| Other Non Operating Income (Expenses) | -1,027 | -961.36 | -904.24 | -844.92 | -694.16 | Upgrade
|
| EBT Excluding Unusual Items | 8,021 | -99,212 | -106,195 | -118,984 | 3,754 | Upgrade
|
| Gain (Loss) on Sale of Assets | 49.84 | 23,448 | 72 | 25,668 | 76.36 | Upgrade
|
| Other Unusual Items | - | - | - | - | 2,676 | Upgrade
|
| Pretax Income | 8,071 | -75,764 | -106,123 | -93,316 | 6,507 | Upgrade
|
| Income Tax Expense | 2,926 | 4,153 | 4,566 | 288.46 | 332.91 | Upgrade
|
| Earnings From Continuing Operations | 5,146 | -79,917 | -110,689 | -93,604 | 6,174 | Upgrade
|
| Minority Interest in Earnings | -192.85 | -391.96 | -230.93 | 60.53 | -74.43 | Upgrade
|
| Net Income | 4,953 | -80,309 | -110,920 | -93,544 | 6,099 | Upgrade
|
| Net Income to Common | 4,953 | -80,309 | -110,920 | -93,544 | 6,099 | Upgrade
|
| Net Income Growth | - | - | - | - | -57.39% | Upgrade
|
| Shares Outstanding (Basic) | 33,250 | 33,250 | 33,250 | 33,250 | 33,250 | Upgrade
|
| Shares Outstanding (Diluted) | 33,250 | 33,250 | 33,250 | 33,250 | 33,250 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | 17.70% | Upgrade
|
| EPS (Basic) | 0.15 | -2.42 | -3.34 | -2.81 | 0.18 | Upgrade
|
| EPS (Diluted) | 0.15 | -2.42 | -3.34 | -2.81 | 0.18 | Upgrade
|
| EPS Growth | - | - | - | - | -63.80% | Upgrade
|
| Free Cash Flow | -164,870 | -339,941 | -95,595 | -339,291 | -263,276 | Upgrade
|
| Free Cash Flow Per Share | -4.96 | -10.22 | -2.88 | -10.20 | -7.92 | Upgrade
|
| Gross Margin | 48.41% | 32.19% | 36.25% | 36.05% | 49.65% | Upgrade
|
| Operating Margin | 15.92% | -9.38% | -14.89% | -23.27% | 4.85% | Upgrade
|
| Profit Margin | 1.13% | -25.17% | -45.71% | -35.92% | 2.10% | Upgrade
|
| Free Cash Flow Margin | -37.49% | -106.56% | -39.39% | -130.28% | -90.49% | Upgrade
|
| EBITDA | 96,342 | -4,412 | -14,554 | -37,714 | 31,395 | Upgrade
|
| EBITDA Margin | 21.91% | -1.38% | -6.00% | -14.48% | 10.79% | Upgrade
|
| D&A For EBITDA | 26,326 | 25,516 | 21,585 | 22,878 | 17,297 | Upgrade
|
| EBIT | 70,016 | -29,928 | -36,139 | -60,591 | 14,098 | Upgrade
|
| EBIT Margin | 15.92% | -9.38% | -14.89% | -23.27% | 4.85% | Upgrade
|
| Effective Tax Rate | 36.25% | - | - | - | 5.12% | Upgrade
|
| Advertising Expenses | 556.44 | 490.32 | 332.36 | 621.1 | 204.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.